Leveraged loans, news in brief - 17 October 2014

By Ross Lancaster
16 Oct 2014

Amdipharm Mercury - Tikehau

Amdipharm Mercury sets price guidance on £984m loan

UK pharmaceuticals group Amdipharm Mercury has set out price guidance on its £984m refinancing and recapitalisation loan, which will raise its net leverage ratio from 3.4 to 5.5 times.

The largest tranche is an ...

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free trial